Inflammatory and toxic secretions, such as tumor necrosis factor alpha (TNF-α), interleukin 6 (IL-6), interleukin 1 beta (IL-1β), and nitric oxide (NO), partially underlie the disease-promoting impact of myeloid cells in MS [8, 9]. This evidence concerns the gene IL6 and myeloid sarcoma.